Qualigen Therapeutics Inc Share Price

NASDAQ: QLGN

Small Cap

$2.19

+0.19

(+9.49%)

Live

as on September 17, 2025 at 11:39 pm IST

$₹

Qualigen Therapeutics Inc Stock Performance

as on September 17, 2025 at 11:39 pm IST

Day's Low
Day's High
$2.1
Day's Price Range
$3.05
$2.19
4.11%
Downside
39.27%
Upside
52 Week's Low
52 Week's High
$1.61
52-Week Price Range
$10.45
$2.19
26.48%
Downside
377.17%
Upside

Qualigen Therapeutics Inc share price movements today

Previous Close: $2.00
Open: $2.10
Volume: 4.7M
Day's Low - High: $2.1 - $3.05
52 Week Low - High: $1.61 - $10.45

Qualigen Therapeutics Inc Historical Returns

1 Month Return: + 5.27 %
3 Month Return: -43.02 %
1 Year Return: -77.49 %
3 Year Return: -98.75 %
5 Year Return: -99.91 %

Qualigen Therapeutics Inc Stock Fundamentals & Key Indicators

Check Qualigen Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.4M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.32

Industry PE ratio

P/B Ratio

0.3165

PEG Ratio

EBITDA

-6.9M

Revenue (TTM)

5.0M

Profit Margin

0.00%

Return On Equity TTM

-841.66%

Qualigen Therapeutics Inc Stock Valuation

Track how Qualigen Therapeutics Inc P/E has moved over time to understand its valuation trends.

Qualigen Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (182.95x)

September 30, 2021

Industry (0.00x)

September 17, 2025

Today (0.32x)

September 17, 2025

Highest (182.95x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 0.32x

Qualigen Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Qualigen Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Qualigen Therapeutics Inc	BUY	$3.4M	-99.91%	0.32	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Qualigen Therapeutics Inc Stock including INR - Dollar returns

The Qualigen Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Qualigen Therapeutics Inc investment value today

Current value as on today

₹29,260

Returns

₹70,740

(-70.74%)

Returns from Qualigen Therapeutics Inc Stock

₹75,338 (-75.34%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Qualigen Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Qualigen Therapeutics Inc. Average target price of $5

Qualigen Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Qualigen Therapeutics Inc.

What analysts predicted

56.2%UPSIDE

Target Price

Current Price

$2.19

Analyzed by

7 Analysts

Target

$5.00

Qualigen Therapeutics Inc target price $5, a slight upside of 56.2% compared to current price of $2.19. According to 7 analysts rating.

Qualigen Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Qualigen Therapeutics Inc Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-63% versus previous 30 day period

Qualigen Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	1	1	7	-	-	-	-	-	2	-
Gross Profit	0	0	2	0	0	0	0	-	1	-
Operating Income	-3	-3	-2	-2	-1	-1	-1	0	-1	-1
EBITDA	-3	-3	-2	-2	-1	-1	-1	-	0	-1
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	-	-	-	-	-	-
Income Before Tax	-4	-3	-3	-2	-2	-1	-1	0	0	-1
Income Tax Expense	0	0	0	0	0	0	0	-	0	0
Net Income	-4	-3	-3	-2	-2	-1	-1	0	0	-1
Net Profit Margin	-255.56%	-212.92%	-46.03%	0.00%	0.00%	0.00%	0.00%	0.00%	-38.25%	0.00%

Qualigen Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	9	5	5	4	5	4	5	-
Gross Profit	-7	-16	1	-2	1	0	0	-
Operating Income	-15	-33	-1	-11	-22	-17	-11	-5
EBITDA	-15	-33	-10	-11	-22	-13	-11	-5
Interest Expense	-	-	0	0	0	0	1	0
Depreciation	-	-	0	0	0	0	0	-
Income Before Tax	-7	-16	-1	-20	-17	-21	-12	-6
Income Tax Expense	0	0	0	0	0	0	0	0
Net Income	-7	-16	-1	-20	-17	-21	-13	-6
Net Profit Margin	-80.44%	-290.69%	-32.16%	-474.16%	-316.55%	-422.08%	-257.79%	0.00%

Qualigen Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-2	-2	-2	-1	-1	0	-1	-1
Operating Cash Flow	-2	0	-5	0	-1	-1	-2	-2	-1
Investing Cash Flow	0	4	0	-	0	-1	-	-1	-1
Financing Cash Flow	0	0	0	0	1	3	4	4	2
Change in Cash	-3	0	-1	0	0	0	0	0	0

Qualigen Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-18	-7	-16	-1	-20	-17	-21	-12	-6
Operating Cash Flow	-15	-7	-13	0	-9	-14	-13	-10	-6
Investing Cash Flow	0	0	0	0	0	0	0	4	-1
Financing Cash Flow	6	22	5	0	33	8	2	0	9
Change in Cash	-8	15	-14	0	0	-6	-10	-6	0

Global Institutional Holdings in Qualigen Therapeutics Inc

Funds	Holdings
FNY Investment Advisers, LLC	0.46%
BlackRock Inc	0.03%
Tower Research Capital LLC	0.02%
HARBOUR INVESTMENTS, INC.	0.02%
Bank of America Corp	0%

See all

Insights on Qualigen Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 145.6%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 215.2%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -855.82K → -1.68M (in $), with an average decrease of 96.9% per quarter
NEGATIVE IMPACT
Price Dip
In the last 3 months, QLGN stock has moved down by -43.0%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 7.94M → 2.23M (in $), with an average decrease of 71.8% per quarter

About Qualigen Therapeutics Inc

Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing treatments for adult and pediatric cancers. The Company’s business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS). Its lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells (such as pancreatic cancer). Its Pan-RAS program, which is at the preclinical stage, consists of a family of rat sarcoma virus (RAS) oncogene protein-protein interaction inhibitor small molecules inhibits or block mutated RAS genes’ proteins from binding to their effector proteins thereby leaving the proteins from the mutated RAS unable to cause further harm. Its QN-302 is in a Phase 1a clinical trial.

Organisation	Qualigen Therapeutics Inc
Headquarters	5857 Owens Avenue, Carlsbad, CA, United States, 92008
Industry	Health Technology
CEO	Mr. Kevin A. Richardson II
E-voting on shares	Click here to vote

Key Management of Qualigen Therapeutics Inc

Name	Title
Mr. Kevin A. Richardson II	Interim CEO, Interim CFO, Chief Accounting Officer & Chairman of the Board
Mr. Robert W. Campbell Becher	President & Director
Mr. Michael S. Poirier	Chief Operating Officer
Mr. Christopher L. Lotz	VP of Finance & Corporate Secretary

FAQs

What is Qualigen Therapeutics Inc share price today?

Qualigen Therapeutics Inc share price today is $2.19 as on September 17, 2025 at 11:39 pm IST. Qualigen Therapeutics Inc share today touched a day high of $3.05 and a low of $2.1.

What is the 52 week high and 52 week low for Qualigen Therapeutics Inc share?

Qualigen Therapeutics Inc share touched a 52 week high of $10.45 on October 25, 2024 and a 52 week low of $1.61 on August 13, 2025. Qualigen Therapeutics Inc stock price today i.e. September 17, 2025 at 11:39 pm IST is trending at $2.19,which is 79.04% down from its 52 week high and 36.02% up from its 52 week low.

What is Qualigen Therapeutics Inc's market capitalisation today?

Qualigen Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 11:39 pm IST.

How to invest in Qualigen Therapeutics Inc Stock (QLGN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Qualigen Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Qualigen Therapeutics Inc Shares that will get you 0.6849 shares as per Qualigen Therapeutics Inc share price of $2.19 per share as on September 17, 2025 at 11:39 pm IST.

What is the minimum amount required to buy Qualigen Therapeutics Inc Stock (QLGN) from India?

Indian investors can start investing in Qualigen Therapeutics Inc (QLGN) shares with as little as ₹87.816 or $1 (as of September 17, 2025 at 11:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Qualigen Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 11:40 pm IST). Based on Qualigen Therapeutics Inc share’s latest price of $2.19 as on September 17, 2025 at 11:39 pm IST, you will get 4.5662 shares of Qualigen Therapeutics Inc. Learn more about fractional shares .

What are the returns that Qualigen Therapeutics Inc has given to Indian investors in the last 5 years?

Qualigen Therapeutics Inc stock has given -99.91% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?